Nasal Platform for Therapeutics

About Akita Biosciences

Akita Biosciences is a private, preclinical-stage biotech innovator based in San Diego, CA, with foundational IP from Harvard's Brigham and Women's Hospital. The company has developed a unique gel-forming nasal spray platform designed to overcome key limitations of traditional nasal delivery, such as short contact time and poor absorption. Its technology has a dual focus: enabling preventive health by blocking and neutralizing airborne threats, and enhancing the precision delivery of therapeutics. Akita has gained notable recognition, including being named to Fast Company's 2025 World's Most Innovative Companies list for its Profi Nasal Spray.

Therapeutic Areas